nodes	percent_of_prediction	percent_of_DWPC	metapath
Vandetanib—LYN—blood plasma—Creutzfeldt-Jakob disease	0.0202	0.0287	CbGeAlD
Vandetanib—FLT3—blood plasma—Creutzfeldt-Jakob disease	0.0172	0.0245	CbGeAlD
Vandetanib—BLK—Glypican 1 network—PRNP—Creutzfeldt-Jakob disease	0.013	0.0435	CbGpPWpGaD
Vandetanib—FGR—Glypican 1 network—PRNP—Creutzfeldt-Jakob disease	0.0129	0.0434	CbGpPWpGaD
Vandetanib—FYN—blood plasma—Creutzfeldt-Jakob disease	0.0129	0.0183	CbGeAlD
Vandetanib—STK10—blood plasma—Creutzfeldt-Jakob disease	0.0115	0.0164	CbGeAlD
Vandetanib—TYRO3—brainstem—Creutzfeldt-Jakob disease	0.0115	0.0164	CbGeAlD
Vandetanib—SRC—blood plasma—Creutzfeldt-Jakob disease	0.0112	0.0159	CbGeAlD
Vandetanib—VEGFA—Glypican 1 network—PRNP—Creutzfeldt-Jakob disease	0.0108	0.0362	CbGpPWpGaD
Vandetanib—BLK—lymphoid tissue—Creutzfeldt-Jakob disease	0.0108	0.0153	CbGeAlD
Vandetanib—YES1—Glypican 1 network—PRNP—Creutzfeldt-Jakob disease	0.0104	0.035	CbGpPWpGaD
Vandetanib—KDR—blood plasma—Creutzfeldt-Jakob disease	0.0103	0.0146	CbGeAlD
Vandetanib—STK35—brainstem—Creutzfeldt-Jakob disease	0.00958	0.0136	CbGeAlD
Vandetanib—PLK4—lymphoid tissue—Creutzfeldt-Jakob disease	0.0084	0.012	CbGeAlD
Vandetanib—TYRO3—lymphoid tissue—Creutzfeldt-Jakob disease	0.00789	0.0112	CbGeAlD
Vandetanib—LYN—lymphoid tissue—Creutzfeldt-Jakob disease	0.00785	0.0112	CbGeAlD
Vandetanib—LYN—Glypican 1 network—PRNP—Creutzfeldt-Jakob disease	0.00777	0.0261	CbGpPWpGaD
Vandetanib—FYN—Glypican 1 network—PRNP—Creutzfeldt-Jakob disease	0.00765	0.0257	CbGpPWpGaD
Vandetanib—EPHA8—central nervous system—Creutzfeldt-Jakob disease	0.0075	0.0107	CbGeAlD
Vandetanib—EPHA8—cerebellum—Creutzfeldt-Jakob disease	0.00733	0.0104	CbGeAlD
Vandetanib—FYN—brainstem—Creutzfeldt-Jakob disease	0.00731	0.0104	CbGeAlD
Vandetanib—TYRO3—spinal cord—Creutzfeldt-Jakob disease	0.00715	0.0102	CbGeAlD
Vandetanib—EPHA5—spinal cord—Creutzfeldt-Jakob disease	0.00715	0.0102	CbGeAlD
Vandetanib—FLT3—lymphoid tissue—Creutzfeldt-Jakob disease	0.00671	0.00955	CbGeAlD
Vandetanib—LCK—Glypican 1 network—PRNP—Creutzfeldt-Jakob disease	0.00637	0.0214	CbGpPWpGaD
Vandetanib—SRC—GP1b-IX-V activation signalling—YWHAZ—Creutzfeldt-Jakob disease	0.00631	0.0212	CbGpPWpGaD
Vandetanib—EPHA6—central nervous system—Creutzfeldt-Jakob disease	0.00625	0.00891	CbGeAlD
Vandetanib—LTK—brain—Creutzfeldt-Jakob disease	0.00621	0.00884	CbGeAlD
Vandetanib—FLT4—lymphoid tissue—Creutzfeldt-Jakob disease	0.00609	0.00868	CbGeAlD
Vandetanib—EPHA8—brain—Creutzfeldt-Jakob disease	0.00596	0.00848	CbGeAlD
Vandetanib—IRAK4—lymphoid tissue—Creutzfeldt-Jakob disease	0.00592	0.00843	CbGeAlD
Vandetanib—MAP2K5—brainstem—Creutzfeldt-Jakob disease	0.00584	0.00831	CbGeAlD
Vandetanib—EPHA5—central nervous system—Creutzfeldt-Jakob disease	0.0058	0.00826	CbGeAlD
Vandetanib—TYRO3—central nervous system—Creutzfeldt-Jakob disease	0.0058	0.00826	CbGeAlD
Vandetanib—ERBB3—lymphoid tissue—Creutzfeldt-Jakob disease	0.0058	0.00826	CbGeAlD
Vandetanib—LYN—central nervous system—Creutzfeldt-Jakob disease	0.00577	0.00822	CbGeAlD
Vandetanib—BMPR1B—central nervous system—Creutzfeldt-Jakob disease	0.00568	0.00809	CbGeAlD
Vandetanib—MAP3K19—central nervous system—Creutzfeldt-Jakob disease	0.00568	0.00809	CbGeAlD
Vandetanib—EPHA5—cerebellum—Creutzfeldt-Jakob disease	0.00567	0.00808	CbGeAlD
Vandetanib—TYRO3—cerebellum—Creutzfeldt-Jakob disease	0.00567	0.00808	CbGeAlD
Vandetanib—SRC—Glypican 1 network—PRNP—Creutzfeldt-Jakob disease	0.00564	0.0189	CbGpPWpGaD
Vandetanib—BMPR1B—cerebellum—Creutzfeldt-Jakob disease	0.00556	0.00791	CbGeAlD
Vandetanib—RIPK2—spinal cord—Creutzfeldt-Jakob disease	0.00549	0.00782	CbGeAlD
Vandetanib—RIPK2—Downstream TCR signaling—HLA-DQB1—Creutzfeldt-Jakob disease	0.00549	0.0184	CbGpPWpGaD
Vandetanib—VEGFA—spinal cord—Creutzfeldt-Jakob disease	0.00548	0.0078	CbGeAlD
Vandetanib—MKNK1—lymphoid tissue—Creutzfeldt-Jakob disease	0.00545	0.00775	CbGeAlD
Vandetanib—FGR—lymphoid tissue—Creutzfeldt-Jakob disease	0.00538	0.00766	CbGeAlD
Vandetanib—RET—lymphoid tissue—Creutzfeldt-Jakob disease	0.00538	0.00766	CbGeAlD
Vandetanib—IRAK4—spinal cord—Creutzfeldt-Jakob disease	0.00536	0.00764	CbGeAlD
Vandetanib—AXL—lymphoid tissue—Creutzfeldt-Jakob disease	0.00536	0.00763	CbGeAlD
Vandetanib—ERBB3—spinal cord—Creutzfeldt-Jakob disease	0.00526	0.00749	CbGeAlD
Vandetanib—LCK—Translocation of ZAP-70 to Immunological synapse—HLA-DQB1—Creutzfeldt-Jakob disease	0.00502	0.0168	CbGpPWpGaD
Vandetanib—FYN—lymphoid tissue—Creutzfeldt-Jakob disease	0.00501	0.00714	CbGeAlD
Vandetanib—EPHA6—brain—Creutzfeldt-Jakob disease	0.00497	0.00707	CbGeAlD
Vandetanib—MKNK1—spinal cord—Creutzfeldt-Jakob disease	0.00494	0.00703	CbGeAlD
Vandetanib—PLK4—brain—Creutzfeldt-Jakob disease	0.0049	0.00698	CbGeAlD
Vandetanib—TEK—lymphoid tissue—Creutzfeldt-Jakob disease	0.0049	0.00698	CbGeAlD
Vandetanib—MAP4K5—lymphoid tissue—Creutzfeldt-Jakob disease	0.0049	0.00698	CbGeAlD
Vandetanib—RET—spinal cord—Creutzfeldt-Jakob disease	0.00488	0.00694	CbGeAlD
Vandetanib—AXL—spinal cord—Creutzfeldt-Jakob disease	0.00486	0.00692	CbGeAlD
Vandetanib—STK35—central nervous system—Creutzfeldt-Jakob disease	0.00483	0.00688	CbGeAlD
Vandetanib—FLT3—cerebellum—Creutzfeldt-Jakob disease	0.00482	0.00687	CbGeAlD
Vandetanib—STK35—cerebellum—Creutzfeldt-Jakob disease	0.00472	0.00673	CbGeAlD
Vandetanib—SLK—spinal cord—Creutzfeldt-Jakob disease	0.00468	0.00666	CbGeAlD
Vandetanib—LCK—Phosphorylation of CD3 and TCR zeta chains—HLA-DQB1—Creutzfeldt-Jakob disease	0.00461	0.0155	CbGpPWpGaD
Vandetanib—TYRO3—brain—Creutzfeldt-Jakob disease	0.00461	0.00656	CbGeAlD
Vandetanib—EPHA5—brain—Creutzfeldt-Jakob disease	0.00461	0.00656	CbGeAlD
Vandetanib—ABL2—cerebellum—Creutzfeldt-Jakob disease	0.0046	0.00656	CbGeAlD
Vandetanib—LYN—brain—Creutzfeldt-Jakob disease	0.00458	0.00653	CbGeAlD
Vandetanib—FYN—spinal cord—Creutzfeldt-Jakob disease	0.00455	0.00647	CbGeAlD
Vandetanib—YES1—lymphoid tissue—Creutzfeldt-Jakob disease	0.00453	0.00644	CbGeAlD
Vandetanib—BMPR1B—brain—Creutzfeldt-Jakob disease	0.00451	0.00643	CbGeAlD
Vandetanib—MAP3K19—brain—Creutzfeldt-Jakob disease	0.00451	0.00643	CbGeAlD
Vandetanib—ABL1—brainstem—Creutzfeldt-Jakob disease	0.0045	0.00641	CbGeAlD
Vandetanib—EGFR—cerebellum—Creutzfeldt-Jakob disease	0.00449	0.0064	CbGeAlD
Vandetanib—STK10—lymphoid tissue—Creutzfeldt-Jakob disease	0.00448	0.00639	CbGeAlD
Vandetanib—MAP4K5—spinal cord—Creutzfeldt-Jakob disease	0.00444	0.00633	CbGeAlD
Vandetanib—TEK—spinal cord—Creutzfeldt-Jakob disease	0.00444	0.00633	CbGeAlD
Vandetanib—FMO1—central nervous system—Creutzfeldt-Jakob disease	0.00442	0.00629	CbGeAlD
Vandetanib—RIPK2—cerebellum—Creutzfeldt-Jakob disease	0.00436	0.0062	CbGeAlD
Vandetanib—SRC—lymphoid tissue—Creutzfeldt-Jakob disease	0.00435	0.0062	CbGeAlD
Vandetanib—IRAK4—central nervous system—Creutzfeldt-Jakob disease	0.00435	0.0062	CbGeAlD
Vandetanib—VEGFA—cerebellum—Creutzfeldt-Jakob disease	0.00434	0.00619	CbGeAlD
Vandetanib—ERBB3—central nervous system—Creutzfeldt-Jakob disease	0.00427	0.00607	CbGeAlD
Vandetanib—IRAK4—cerebellum—Creutzfeldt-Jakob disease	0.00425	0.00606	CbGeAlD
Vandetanib—EPHB6—spinal cord—Creutzfeldt-Jakob disease	0.00425	0.00605	CbGeAlD
Vandetanib—ERBB3—cerebellum—Creutzfeldt-Jakob disease	0.00417	0.00594	CbGeAlD
Vandetanib—LCK—PD-1 signaling—HLA-DQB1—Creutzfeldt-Jakob disease	0.00412	0.0138	CbGpPWpGaD
Vandetanib—YES1—spinal cord—Creutzfeldt-Jakob disease	0.0041	0.00584	CbGeAlD
Vandetanib—RIPK2—TCR signaling—HLA-DQB1—Creutzfeldt-Jakob disease	0.0041	0.0138	CbGpPWpGaD
Vandetanib—MKNK1—central nervous system—Creutzfeldt-Jakob disease	0.00401	0.0057	CbGeAlD
Vandetanib—KDR—lymphoid tissue—Creutzfeldt-Jakob disease	0.004	0.0057	CbGeAlD
Vandetanib—ERBB3—a6b1 and a6b4 Integrin signaling—YWHAZ—Creutzfeldt-Jakob disease	0.00399	0.0134	CbGpPWpGaD
Vandetanib—RET—central nervous system—Creutzfeldt-Jakob disease	0.00396	0.00563	CbGeAlD
Vandetanib—FGR—central nervous system—Creutzfeldt-Jakob disease	0.00396	0.00563	CbGeAlD
Vandetanib—SRC—spinal cord—Creutzfeldt-Jakob disease	0.00395	0.00562	CbGeAlD
Vandetanib—AXL—central nervous system—Creutzfeldt-Jakob disease	0.00394	0.00561	CbGeAlD
Vandetanib—MKNK1—cerebellum—Creutzfeldt-Jakob disease	0.00391	0.00557	CbGeAlD
Vandetanib—RET—cerebellum—Creutzfeldt-Jakob disease	0.00387	0.00551	CbGeAlD
Vandetanib—AXL—cerebellum—Creutzfeldt-Jakob disease	0.00385	0.00548	CbGeAlD
Vandetanib—STK35—brain—Creutzfeldt-Jakob disease	0.00384	0.00546	CbGeAlD
Vandetanib—FMO3—central nervous system—Creutzfeldt-Jakob disease	0.00382	0.00544	CbGeAlD
Vandetanib—ABL2—brain—Creutzfeldt-Jakob disease	0.00374	0.00532	CbGeAlD
Vandetanib—SLK—cerebellum—Creutzfeldt-Jakob disease	0.00371	0.00528	CbGeAlD
Vandetanib—FYN—central nervous system—Creutzfeldt-Jakob disease	0.00369	0.00525	CbGeAlD
Vandetanib—EGFR—brain—Creutzfeldt-Jakob disease	0.00365	0.0052	CbGeAlD
Vandetanib—MAP2K5—spinal cord—Creutzfeldt-Jakob disease	0.00363	0.00517	CbGeAlD
Vandetanib—KDR—spinal cord—Creutzfeldt-Jakob disease	0.00363	0.00517	CbGeAlD
Vandetanib—FYN—cerebellum—Creutzfeldt-Jakob disease	0.0036	0.00513	CbGeAlD
Vandetanib—TEK—central nervous system—Creutzfeldt-Jakob disease	0.0036	0.00513	CbGeAlD
Vandetanib—MAP4K5—central nervous system—Creutzfeldt-Jakob disease	0.0036	0.00513	CbGeAlD
Vandetanib—YES1—Interleukin-3, 5 and GM-CSF signaling—YWHAZ—Creutzfeldt-Jakob disease	0.00356	0.012	CbGpPWpGaD
Vandetanib—FLT4—brain—Creutzfeldt-Jakob disease	0.00356	0.00507	CbGeAlD
Vandetanib—FYN—NCAM signaling for neurite out-growth—PRNP—Creutzfeldt-Jakob disease	0.00355	0.0119	CbGpPWpGaD
Vandetanib—RIPK2—brain—Creutzfeldt-Jakob disease	0.00354	0.00504	CbGeAlD
Vandetanib—VEGFA—brain—Creutzfeldt-Jakob disease	0.00353	0.00502	CbGeAlD
Vandetanib—TEK—cerebellum—Creutzfeldt-Jakob disease	0.00352	0.00502	CbGeAlD
Vandetanib—MAP4K5—cerebellum—Creutzfeldt-Jakob disease	0.00352	0.00502	CbGeAlD
Vandetanib—FMO1—brain—Creutzfeldt-Jakob disease	0.00351	0.005	CbGeAlD
Vandetanib—CYP3A4—blood plasma—Creutzfeldt-Jakob disease	0.00349	0.00496	CbGeAlD
Vandetanib—PDGFRB—lymphoid tissue—Creutzfeldt-Jakob disease	0.00347	0.00494	CbGeAlD
Vandetanib—IRAK4—brain—Creutzfeldt-Jakob disease	0.00346	0.00492	CbGeAlD
Vandetanib—EPHB6—central nervous system—Creutzfeldt-Jakob disease	0.00344	0.0049	CbGeAlD
Vandetanib—ERBB3—brain—Creutzfeldt-Jakob disease	0.00339	0.00482	CbGeAlD
Vandetanib—EPHB6—cerebellum—Creutzfeldt-Jakob disease	0.00337	0.00479	CbGeAlD
Vandetanib—YES1—central nervous system—Creutzfeldt-Jakob disease	0.00333	0.00474	CbGeAlD
Vandetanib—STK10—central nervous system—Creutzfeldt-Jakob disease	0.0033	0.0047	CbGeAlD
Vandetanib—YES1—cerebellum—Creutzfeldt-Jakob disease	0.00325	0.00463	CbGeAlD
Vandetanib—STK10—cerebellum—Creutzfeldt-Jakob disease	0.00322	0.00459	CbGeAlD
Vandetanib—SRC—central nervous system—Creutzfeldt-Jakob disease	0.0032	0.00456	CbGeAlD
Vandetanib—MKNK1—brain—Creutzfeldt-Jakob disease	0.00318	0.00453	CbGeAlD
Vandetanib—LCK—Generation of second messenger molecules—HLA-DQB1—Creutzfeldt-Jakob disease	0.00317	0.0106	CbGpPWpGaD
Vandetanib—PDGFRB—spinal cord—Creutzfeldt-Jakob disease	0.00314	0.00447	CbGeAlD
Vandetanib—RET—brain—Creutzfeldt-Jakob disease	0.00314	0.00447	CbGeAlD
Vandetanib—FGR—brain—Creutzfeldt-Jakob disease	0.00314	0.00447	CbGeAlD
Vandetanib—SRC—cerebellum—Creutzfeldt-Jakob disease	0.00313	0.00446	CbGeAlD
Vandetanib—AXL—brain—Creutzfeldt-Jakob disease	0.00313	0.00445	CbGeAlD
Vandetanib—ABL1—lymphoid tissue—Creutzfeldt-Jakob disease	0.00309	0.0044	CbGeAlD
Vandetanib—LYN—GMCSF-mediated signaling events—YWHAZ—Creutzfeldt-Jakob disease	0.00305	0.0103	CbGpPWpGaD
Vandetanib—FMO3—brain—Creutzfeldt-Jakob disease	0.00303	0.00432	CbGeAlD
Vandetanib—SLK—brain—Creutzfeldt-Jakob disease	0.00301	0.00429	CbGeAlD
Vandetanib—ORM1—spinal cord—Creutzfeldt-Jakob disease	0.00295	0.0042	CbGeAlD
Vandetanib—KDR—central nervous system—Creutzfeldt-Jakob disease	0.00295	0.00419	CbGeAlD
Vandetanib—MAP2K5—central nervous system—Creutzfeldt-Jakob disease	0.00295	0.00419	CbGeAlD
Vandetanib—FYN—brain—Creutzfeldt-Jakob disease	0.00293	0.00417	CbGeAlD
Vandetanib—ABL2—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.00291	0.00978	CbGpPWpGaD
Vandetanib—EPHA5—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.00291	0.00978	CbGpPWpGaD
Vandetanib—MAP2K5—cerebellum—Creutzfeldt-Jakob disease	0.00288	0.0041	CbGeAlD
Vandetanib—KDR—cerebellum—Creutzfeldt-Jakob disease	0.00288	0.0041	CbGeAlD
Vandetanib—MAP4K5—brain—Creutzfeldt-Jakob disease	0.00286	0.00407	CbGeAlD
Vandetanib—TEK—brain—Creutzfeldt-Jakob disease	0.00286	0.00407	CbGeAlD
Vandetanib—YES1—Costimulation by the CD28 family—HLA-DQB1—Creutzfeldt-Jakob disease	0.00283	0.00952	CbGpPWpGaD
Vandetanib—EPHA8—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.00281	0.00944	CbGpPWpGaD
Vandetanib—ABL1—spinal cord—Creutzfeldt-Jakob disease	0.0028	0.00399	CbGeAlD
Vandetanib—RET—SIDS Susceptibility Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.00279	0.00938	CbGpPWpGaD
Vandetanib—EPHB6—brain—Creutzfeldt-Jakob disease	0.00273	0.00389	CbGeAlD
Vandetanib—LYN—Interleukin-3, 5 and GM-CSF signaling—YWHAZ—Creutzfeldt-Jakob disease	0.00266	0.00893	CbGpPWpGaD
Vandetanib—YES1—brain—Creutzfeldt-Jakob disease	0.00264	0.00376	CbGeAlD
Vandetanib—STK10—brain—Creutzfeldt-Jakob disease	0.00262	0.00373	CbGeAlD
Vandetanib—FYN—Interleukin-3, 5 and GM-CSF signaling—YWHAZ—Creutzfeldt-Jakob disease	0.00262	0.00879	CbGpPWpGaD
Vandetanib—SRC—NCAM signaling for neurite out-growth—PRNP—Creutzfeldt-Jakob disease	0.00261	0.00878	CbGpPWpGaD
Vandetanib—EPHB6—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.00261	0.00877	CbGpPWpGaD
Vandetanib—VEGFA—Allograft Rejection—HLA-DQB1—Creutzfeldt-Jakob disease	0.0026	0.00874	CbGpPWpGaD
Vandetanib—LCK—Downstream TCR signaling—HLA-DQB1—Creutzfeldt-Jakob disease	0.0026	0.00872	CbGpPWpGaD
Vandetanib—PDGFRB—central nervous system—Creutzfeldt-Jakob disease	0.00255	0.00363	CbGeAlD
Vandetanib—SRC—brain—Creutzfeldt-Jakob disease	0.00254	0.00362	CbGeAlD
Vandetanib—PDGFRB—cerebellum—Creutzfeldt-Jakob disease	0.00249	0.00355	CbGeAlD
Vandetanib—IRAK4—Signaling by Interleukins—YWHAZ—Creutzfeldt-Jakob disease	0.00248	0.00834	CbGpPWpGaD
Vandetanib—EPHA6—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.00246	0.00825	CbGpPWpGaD
Vandetanib—SRC—Alpha4 beta1 integrin signaling events—YWHAZ—Creutzfeldt-Jakob disease	0.00243	0.00815	CbGpPWpGaD
Vandetanib—ORM1—central nervous system—Creutzfeldt-Jakob disease	0.00239	0.00341	CbGeAlD
Vandetanib—MAP2K5—brain—Creutzfeldt-Jakob disease	0.00234	0.00333	CbGeAlD
Vandetanib—KDR—brain—Creutzfeldt-Jakob disease	0.00234	0.00333	CbGeAlD
Vandetanib—SRC—Class I PI3K signaling events mediated by Akt—YWHAZ—Creutzfeldt-Jakob disease	0.00232	0.00778	CbGpPWpGaD
Vandetanib—ABL1—central nervous system—Creutzfeldt-Jakob disease	0.00227	0.00324	CbGeAlD
Vandetanib—SRC—Trk receptor signaling mediated by PI3K and PLC-gamma—YWHAZ—Creutzfeldt-Jakob disease	0.00226	0.00761	CbGpPWpGaD
Vandetanib—RIPK2—Signaling by Interleukins—YWHAZ—Creutzfeldt-Jakob disease	0.00225	0.00754	CbGpPWpGaD
Vandetanib—ABL1—cerebellum—Creutzfeldt-Jakob disease	0.00222	0.00316	CbGeAlD
Vandetanib—EGFR—a6b1 and a6b4 Integrin signaling—YWHAZ—Creutzfeldt-Jakob disease	0.00222	0.00746	CbGpPWpGaD
Vandetanib—ABL1—Pathogenic Escherichia coli infection—YWHAZ—Creutzfeldt-Jakob disease	0.00221	0.00743	CbGpPWpGaD
Vandetanib—FYN—Pathogenic Escherichia coli infection—YWHAZ—Creutzfeldt-Jakob disease	0.00219	0.00735	CbGpPWpGaD
Vandetanib—LYN—Costimulation by the CD28 family—HLA-DQB1—Creutzfeldt-Jakob disease	0.00211	0.0071	CbGpPWpGaD
Vandetanib—MAP2K5—ErbB1 downstream signaling—YWHAZ—Creutzfeldt-Jakob disease	0.0021	0.00706	CbGpPWpGaD
Vandetanib—FYN—Costimulation by the CD28 family—HLA-DQB1—Creutzfeldt-Jakob disease	0.00208	0.00699	CbGpPWpGaD
Vandetanib—EPHA5—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.00208	0.00698	CbGpPWpGaD
Vandetanib—ABL2—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.00208	0.00698	CbGpPWpGaD
Vandetanib—PDGFRB—brain—Creutzfeldt-Jakob disease	0.00202	0.00288	CbGeAlD
Vandetanib—EPHA8—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.002	0.00673	CbGpPWpGaD
Vandetanib—FMO1—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00197	0.00662	CbGpPWpGaD
Vandetanib—LCK—TCR signaling—HLA-DQB1—Creutzfeldt-Jakob disease	0.00194	0.00652	CbGpPWpGaD
Vandetanib—BLK—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.00192	0.00646	CbGpPWpGaD
Vandetanib—FGR—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.00192	0.00643	CbGpPWpGaD
Vandetanib—FMO3—SIDS Susceptibility Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.00188	0.00631	CbGpPWpGaD
Vandetanib—EPHB6—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.00186	0.00626	CbGpPWpGaD
Vandetanib—ABL1—brain—Creutzfeldt-Jakob disease	0.0018	0.00257	CbGeAlD
Vandetanib—ABCG2—spinal cord—Creutzfeldt-Jakob disease	0.00177	0.00252	CbGeAlD
Vandetanib—EPHA6—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.00175	0.00589	CbGpPWpGaD
Vandetanib—YES1—Signaling by Interleukins—YWHAZ—Creutzfeldt-Jakob disease	0.00174	0.00584	CbGpPWpGaD
Vandetanib—LCK—Costimulation by the CD28 family—HLA-DQB1—Creutzfeldt-Jakob disease	0.00173	0.00582	CbGpPWpGaD
Vandetanib—ABCC1—cerebellum—Creutzfeldt-Jakob disease	0.00169	0.00241	CbGeAlD
Vandetanib—ALB—brain—Creutzfeldt-Jakob disease	0.00166	0.00237	CbGeAlD
Vandetanib—KDR—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.0016	0.00536	CbGpPWpGaD
Vandetanib—KDR—Extracellular matrix organization—CTSD—Creutzfeldt-Jakob disease	0.00155	0.0052	CbGpPWpGaD
Vandetanib—YES1—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.00155	0.00519	CbGpPWpGaD
Vandetanib—SRC—Costimulation by the CD28 family—HLA-DQB1—Creutzfeldt-Jakob disease	0.00153	0.00515	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism of lipids and lipoproteins—MTMR7—Creutzfeldt-Jakob disease	0.00147	0.00493	CbGpPWpGaD
Vandetanib—VEGFA—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.00143	0.00482	CbGpPWpGaD
Vandetanib—EGFR—Direct p53 effectors—CTSD—Creutzfeldt-Jakob disease	0.00142	0.00475	CbGpPWpGaD
Vandetanib—FMO3—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00141	0.00473	CbGpPWpGaD
Vandetanib—ABCG2—cerebellum—Creutzfeldt-Jakob disease	0.0014	0.00199	CbGeAlD
Vandetanib—YES1—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.00139	0.00465	CbGpPWpGaD
Vandetanib—ABCC1—brain—Creutzfeldt-Jakob disease	0.00137	0.00196	CbGeAlD
Vandetanib—ABL1—Cell Cycle—YWHAZ—Creutzfeldt-Jakob disease	0.00135	0.00453	CbGpPWpGaD
Vandetanib—VEGFA—SIDS Susceptibility Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.00134	0.0045	CbGpPWpGaD
Vandetanib—IRAK4—Cytokine Signaling in Immune system—HLA-DQB1—Creutzfeldt-Jakob disease	0.00131	0.00438	CbGpPWpGaD
Vandetanib—LYN—Signaling by Interleukins—YWHAZ—Creutzfeldt-Jakob disease	0.0013	0.00435	CbGpPWpGaD
Vandetanib—FYN—Signaling by Interleukins—YWHAZ—Creutzfeldt-Jakob disease	0.00128	0.00429	CbGpPWpGaD
Vandetanib—RIPK2—Cytokine Signaling in Immune system—HLA-DQB1—Creutzfeldt-Jakob disease	0.00118	0.00396	CbGpPWpGaD
Vandetanib—PDGFRB—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.00118	0.00395	CbGpPWpGaD
Vandetanib—IRAK4—Cytokine Signaling in Immune system—YWHAZ—Creutzfeldt-Jakob disease	0.00116	0.00389	CbGpPWpGaD
Vandetanib—LYN—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.00115	0.00387	CbGpPWpGaD
Vandetanib—ABL1—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.00115	0.00385	CbGpPWpGaD
Vandetanib—KDR—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.00114	0.00382	CbGpPWpGaD
Vandetanib—ABCG2—brain—Creutzfeldt-Jakob disease	0.00114	0.00162	CbGeAlD
Vandetanib—FYN—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.00113	0.00381	CbGpPWpGaD
Vandetanib—EGFR—ErbB1 downstream signaling—YWHAZ—Creutzfeldt-Jakob disease	0.00113	0.00379	CbGpPWpGaD
Vandetanib—FMO1—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.00109	0.00366	CbGpPWpGaD
Vandetanib—LCK—Signaling by Interleukins—YWHAZ—Creutzfeldt-Jakob disease	0.00106	0.00357	CbGpPWpGaD
Vandetanib—RIPK2—Cytokine Signaling in Immune system—YWHAZ—Creutzfeldt-Jakob disease	0.00105	0.00352	CbGpPWpGaD
Vandetanib—LYN—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.00103	0.00347	CbGpPWpGaD
Vandetanib—ABL1—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.00103	0.00345	CbGpPWpGaD
Vandetanib—VEGFA—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.00102	0.00344	CbGpPWpGaD
Vandetanib—FYN—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.00102	0.00342	CbGpPWpGaD
Vandetanib—VEGFA—Platelet activation, signaling and aggregation—YWHAZ—Creutzfeldt-Jakob disease	0.00101	0.00341	CbGpPWpGaD
Vandetanib—CYP3A4—central nervous system—Creutzfeldt-Jakob disease	0.000998	0.00142	CbGeAlD
Vandetanib—YES1—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.000988	0.00332	CbGpPWpGaD
Vandetanib—TEK—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000971	0.00326	CbGpPWpGaD
Vandetanib—SRC—ErbB1 downstream signaling—YWHAZ—Creutzfeldt-Jakob disease	0.000962	0.00323	CbGpPWpGaD
Vandetanib—LCK—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.000945	0.00317	CbGpPWpGaD
Vandetanib—YES1—Cytokine Signaling in Immune system—HLA-DQB1—Creutzfeldt-Jakob disease	0.000913	0.00307	CbGpPWpGaD
Vandetanib—RIPK2—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000892	0.003	CbGpPWpGaD
Vandetanib—EGFR—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.000878	0.00295	CbGpPWpGaD
Vandetanib—BLK—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000858	0.00288	CbGpPWpGaD
Vandetanib—SRC—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.000837	0.00281	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism of lipids and lipoproteins—NPAS2—Creutzfeldt-Jakob disease	0.000811	0.00273	CbGpPWpGaD
Vandetanib—YES1—Cytokine Signaling in Immune system—YWHAZ—Creutzfeldt-Jakob disease	0.000811	0.00272	CbGpPWpGaD
Vandetanib—ALB—Metabolism of lipids and lipoproteins—MTMR7—Creutzfeldt-Jakob disease	0.000797	0.00268	CbGpPWpGaD
Vandetanib—ERBB3—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000786	0.00264	CbGpPWpGaD
Vandetanib—FMO3—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000779	0.00262	CbGpPWpGaD
Vandetanib—SRC—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.000749	0.00252	CbGpPWpGaD
Vandetanib—LYN—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.000737	0.00248	CbGpPWpGaD
Vandetanib—ABL1—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.000734	0.00246	CbGpPWpGaD
Vandetanib—LYN—Platelet activation, signaling and aggregation—YWHAZ—Creutzfeldt-Jakob disease	0.000731	0.00245	CbGpPWpGaD
Vandetanib—FYN—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.000726	0.00244	CbGpPWpGaD
Vandetanib—FYN—Platelet activation, signaling and aggregation—YWHAZ—Creutzfeldt-Jakob disease	0.000719	0.00242	CbGpPWpGaD
Vandetanib—YES1—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.00069	0.00232	CbGpPWpGaD
Vandetanib—LYN—Cytokine Signaling in Immune system—HLA-DQB1—Creutzfeldt-Jakob disease	0.000681	0.00229	CbGpPWpGaD
Vandetanib—FYN—Cytokine Signaling in Immune system—HLA-DQB1—Creutzfeldt-Jakob disease	0.000671	0.00225	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000654	0.0022	CbGpPWpGaD
Vandetanib—RIPK2—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000636	0.00213	CbGpPWpGaD
Vandetanib—EGFR—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.000627	0.00211	CbGpPWpGaD
Vandetanib—FGR—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000626	0.0021	CbGpPWpGaD
Vandetanib—BLK—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000611	0.00205	CbGpPWpGaD
Vandetanib—LYN—Cytokine Signaling in Immune system—YWHAZ—Creutzfeldt-Jakob disease	0.000605	0.00203	CbGpPWpGaD
Vandetanib—LCK—Platelet activation, signaling and aggregation—YWHAZ—Creutzfeldt-Jakob disease	0.000599	0.00201	CbGpPWpGaD
Vandetanib—SRC—Membrane Trafficking—YWHAZ—Creutzfeldt-Jakob disease	0.000598	0.00201	CbGpPWpGaD
Vandetanib—IRAK4—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000598	0.00201	CbGpPWpGaD
Vandetanib—FYN—Cytokine Signaling in Immune system—YWHAZ—Creutzfeldt-Jakob disease	0.000595	0.002	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000575	0.00193	CbGpPWpGaD
Vandetanib—RIPK2—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000564	0.0019	CbGpPWpGaD
Vandetanib—ERBB3—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.00056	0.00188	CbGpPWpGaD
Vandetanib—LCK—Cytokine Signaling in Immune system—HLA-DQB1—Creutzfeldt-Jakob disease	0.000558	0.00188	CbGpPWpGaD
Vandetanib—BLK—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000543	0.00182	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000541	0.00182	CbGpPWpGaD
Vandetanib—SRC—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.000535	0.0018	CbGpPWpGaD
Vandetanib—SRC—Platelet activation, signaling and aggregation—YWHAZ—Creutzfeldt-Jakob disease	0.00053	0.00178	CbGpPWpGaD
Vandetanib—PDGFRB—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000526	0.00177	CbGpPWpGaD
Vandetanib—VEGFA—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000523	0.00176	CbGpPWpGaD
Vandetanib—BLK—Immune System—CTSD—Creutzfeldt-Jakob disease	0.00052	0.00175	CbGpPWpGaD
Vandetanib—FGR—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000519	0.00174	CbGpPWpGaD
Vandetanib—LYN—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000515	0.00173	CbGpPWpGaD
Vandetanib—FYN—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000507	0.0017	CbGpPWpGaD
Vandetanib—YES1—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000505	0.0017	CbGpPWpGaD
Vandetanib—ERBB3—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000498	0.00167	CbGpPWpGaD
Vandetanib—LCK—Cytokine Signaling in Immune system—YWHAZ—Creutzfeldt-Jakob disease	0.000496	0.00166	CbGpPWpGaD
Vandetanib—YES1—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000492	0.00165	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000477	0.0016	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000475	0.0016	CbGpPWpGaD
Vandetanib—MKNK1—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.00047	0.00158	CbGpPWpGaD
Vandetanib—ALB—Metabolism of lipids and lipoproteins—NPAS2—Creutzfeldt-Jakob disease	0.000441	0.00148	CbGpPWpGaD
Vandetanib—EGFR—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000438	0.00147	CbGpPWpGaD
Vandetanib—YES1—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000437	0.00147	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000434	0.00146	CbGpPWpGaD
Vandetanib—IRAK4—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000426	0.00143	CbGpPWpGaD
Vandetanib—LCK—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000422	0.00142	CbGpPWpGaD
Vandetanib—YES1—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000419	0.00141	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000397	0.00133	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000386	0.00129	CbGpPWpGaD
Vandetanib—IRAK4—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000378	0.00127	CbGpPWpGaD
Vandetanib—LYN—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000377	0.00127	CbGpPWpGaD
Vandetanib—ABL1—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000375	0.00126	CbGpPWpGaD
Vandetanib—PDGFRB—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000375	0.00126	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000373	0.00125	CbGpPWpGaD
Vandetanib—BLK—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000371	0.00125	CbGpPWpGaD
Vandetanib—FYN—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000371	0.00125	CbGpPWpGaD
Vandetanib—FGR—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.00037	0.00124	CbGpPWpGaD
Vandetanib—LYN—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000367	0.00123	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000361	0.00121	CbGpPWpGaD
Vandetanib—FYN—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000361	0.00121	CbGpPWpGaD
Vandetanib—ALB—Platelet activation, signaling and aggregation—YWHAZ—Creutzfeldt-Jakob disease	0.000358	0.0012	CbGpPWpGaD
Vandetanib—ALB—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000355	0.00119	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000342	0.00115	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.00034	0.00114	CbGpPWpGaD
Vandetanib—PDGFRB—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000333	0.00112	CbGpPWpGaD
Vandetanib—BLK—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000329	0.00111	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000329	0.00111	CbGpPWpGaD
Vandetanib—FGR—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000328	0.0011	CbGpPWpGaD
Vandetanib—LYN—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000326	0.00109	CbGpPWpGaD
Vandetanib—FYN—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000321	0.00108	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000319	0.00107	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000318	0.00107	CbGpPWpGaD
Vandetanib—LYN—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000312	0.00105	CbGpPWpGaD
Vandetanib—EGFR—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000312	0.00105	CbGpPWpGaD
Vandetanib—ABL1—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000311	0.00104	CbGpPWpGaD
Vandetanib—LCK—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000309	0.00104	CbGpPWpGaD
Vandetanib—FYN—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000307	0.00103	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000302	0.00101	CbGpPWpGaD
Vandetanib—LCK—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000301	0.00101	CbGpPWpGaD
Vandetanib—YES1—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000298	0.001	CbGpPWpGaD
Vandetanib—ERBB3—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000279	0.000936	CbGpPWpGaD
Vandetanib—EGFR—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000277	0.00093	CbGpPWpGaD
Vandetanib—SRC—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000273	0.000918	CbGpPWpGaD
Vandetanib—LCK—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000267	0.000897	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000266	0.000894	CbGpPWpGaD
Vandetanib—EGFR—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000266	0.000892	CbGpPWpGaD
Vandetanib—YES1—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000265	0.00089	CbGpPWpGaD
Vandetanib—LCK—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000256	0.00086	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000236	0.000794	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000227	0.000763	CbGpPWpGaD
Vandetanib—SRC—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000227	0.000761	CbGpPWpGaD
Vandetanib—LYN—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000222	0.000747	CbGpPWpGaD
Vandetanib—ABL1—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000221	0.000744	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000221	0.000743	CbGpPWpGaD
Vandetanib—FYN—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000219	0.000736	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000202	0.00068	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000202	0.000678	CbGpPWpGaD
Vandetanib—LYN—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000198	0.000663	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000197	0.000663	CbGpPWpGaD
Vandetanib—ABL1—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000197	0.00066	CbGpPWpGaD
Vandetanib—ALB—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000196	0.000659	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000195	0.000655	CbGpPWpGaD
Vandetanib—FYN—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000194	0.000653	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000192	0.000644	CbGpPWpGaD
Vandetanib—EGFR—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000189	0.000636	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000186	0.000626	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000185	0.00062	CbGpPWpGaD
Vandetanib—LCK—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000182	0.000612	CbGpPWpGaD
Vandetanib—FYN—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.00018	0.000603	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000177	0.000596	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000171	0.000575	CbGpPWpGaD
Vandetanib—EGFR—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000168	0.000564	CbGpPWpGaD
Vandetanib—ABCC1—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000165	0.000553	CbGpPWpGaD
Vandetanib—LCK—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000162	0.000544	CbGpPWpGaD
Vandetanib—SRC—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000161	0.000542	CbGpPWpGaD
Vandetanib—EGFR—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000155	0.000521	CbGpPWpGaD
Vandetanib—LCK—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000149	0.000502	CbGpPWpGaD
Vandetanib—SRC—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000143	0.000481	CbGpPWpGaD
Vandetanib—SRC—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000132	0.000444	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.00013	0.000438	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000128	0.000429	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000126	0.000422	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000109	0.000365	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000106	0.000356	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000105	0.000352	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	9.27e-05	0.000311	CbGpPWpGaD
